Xometry Q2 2024 Adj. EPS $(0.01) Beats $(0.12) Estimate, Sales $132.595M Beat $128.648M Estimate
Portfolio Pulse from Benzinga Newsdesk
Xometry (NASDAQ:XMTR) reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.01) beating the $(0.12) estimate and sales of $132.595 million surpassing the $128.648 million estimate. This represents a 19.45% increase in sales compared to the same period last year.
August 08, 2024 | 11:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xometry (NASDAQ:XMTR) reported Q2 2024 results that significantly beat analyst expectations, with an adjusted EPS of $(0.01) compared to the $(0.12) estimate and sales of $132.595 million surpassing the $128.648 million estimate. This strong performance indicates positive momentum for the company.
Xometry's better-than-expected earnings and sales figures indicate strong operational performance and positive market reception. The significant beat on EPS and sales suggests potential upward movement in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100